These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 37264374)

  • 1. Deep learning diagnostic and severity-stratification for interstitial lung diseases and chronic obstructive pulmonary disease in digital lung auscultations and ultrasonography: clinical protocol for an observational case-control study.
    Siebert JN; Hartley MA; Courvoisier DS; Salamin M; Robotham L; Doenz J; Barazzone-Argiroffo C; Gervaix A; Bridevaux PO
    BMC Pulm Med; 2023 Jun; 23(1):191. PubMed ID: 37264374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep learning diagnostic and risk-stratification pattern detection for COVID-19 in digital lung auscultations: clinical protocol for a case-control and prospective cohort study.
    Glangetas A; Hartley MA; Cantais A; Courvoisier DS; Rivollet D; Shama DM; Perez A; Spechbach H; Trombert V; Bourquin S; Jaggi M; Barazzone-Argiroffo C; Gervaix A; Siebert JN
    BMC Pulm Med; 2021 Mar; 21(1):103. PubMed ID: 33761909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias.
    Traila D; Oancea C; Tudorache E; Mladinescu OF; Timar B; Tudorache V
    J Int Med Res; 2018 Jan; 46(1):448-456. PubMed ID: 28758849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a CT-based deep learning algorithm to augment non-invasive diagnosis of idiopathic pulmonary fibrosis.
    Maddali MV; Kalra A; Muelly M; Reicher JJ
    Respir Med; 2023; 219():107428. PubMed ID: 37838076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensible machine learning tool to differentially diagnose idiopathic pulmonary fibrosis from other chronic interstitial lung diseases.
    Furukawa T; Oyama S; Yokota H; Kondoh Y; Kataoka K; Johkoh T; Fukuoka J; Hashimoto N; Sakamoto K; Shiratori Y; Hasegawa Y
    Respirology; 2022 Sep; 27(9):739-746. PubMed ID: 35697345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias.
    Morais A; Beltrão M; Sokhatska O; Costa D; Melo N; Mota P; Marques A; Delgado L
    Respir Med; 2015 Aug; 109(8):1063-8. PubMed ID: 26174192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Usual Interstitial Pneumonia Histopathology From Chest CT Imaging With Deep Learning.
    Bratt A; Williams JM; Liu G; Panda A; Patel PP; Walkoff L; Sykes AG; Tandon YK; Francois CJ; Blezek DJ; Larson NB; Erickson BJ; Yi ES; Moua T; Koo CW
    Chest; 2022 Oct; 162(4):815-823. PubMed ID: 35405110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
    Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
    Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
    Xue M; Guo Z; Cai C; Sun B; Wang H
    Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broader criteria of undifferentiated connective tissue disease in idiopathic interstitial pneumonias.
    Kondoh Y; Johkoh T; Fukuoka J; Arakawa H; Tanaka T; Watanabe N; Sakamoto K; Kataoka K; Kimura T; Taniguchi H
    Respir Med; 2015 Mar; 109(3):389-96. PubMed ID: 25682542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: a case-cohort study.
    Walsh SLF; Calandriello L; Silva M; Sverzellati N
    Lancet Respir Med; 2018 Nov; 6(11):837-845. PubMed ID: 30232049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia.
    Yoshimura K; Kono M; Enomoto Y; Nishimoto K; Oyama Y; Yasui H; Hozumi H; Karayama M; Suzuki Y; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Sumikawa H; Johkoh T; Colby TV; Sugimura H; Suda T
    Respir Med; 2018 Apr; 137():167-175. PubMed ID: 29605201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New York Heart Association class and pulmonary artery pressure as prognostic factors of interstitial lung disease survival.
    Carbone RG; Monselise A; Filiberti RA; Penna D; Negrini S; Puppo F
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(7):3045-3052. PubMed ID: 37070907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ThOracic Ultrasound in Idiopathic Pulmonary Fibrosis Evolution (TOUPIE): research protocol of a multicentric prospective study.
    Legué S; Marchand-Adam S; Plantier L; Bayeh BA; Morel H; Mangiapan G; Flament T
    BMJ Open; 2021 Mar; 11(3):e039078. PubMed ID: 33766834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine crackles on chest auscultation in the early diagnosis of idiopathic pulmonary fibrosis: a prospective cohort study.
    Moran-Mendoza O; Ritchie T; Aldhaheri S
    BMJ Open Respir Res; 2021 Jul; 8(1):. PubMed ID: 34233892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep learning in interstitial lung disease-how long until daily practice.
    Trusculescu AA; Manolescu D; Tudorache E; Oancea C
    Eur Radiol; 2020 Nov; 30(11):6285-6292. PubMed ID: 32537728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.